Tile

PharmiWeb Feeds

Latest press releases in the pharmaceutical industry.

4 feeds
Loading tags...
Tile
https://www.pharmiweb.com/rss/press-releases-7-days RSS

PharmiWeb.com Press Releases

PharmiWeb.com | Press Releases in the Pharmaceutical industry
Last seen 10 hours ago • 4 views
Tile
https://www.pharmiweb.com/rss/events RSS

PharmiWeb.com Events

PharmiWeb.com | Events in the Pharmaceutical industry
Last seen 10 hours ago • 5 views
Tile
https://www.pharmiweb.com/rss/pwtoday RSS

PharmiWeb.com PwToday Stories

PharmiWeb.com | PWToday Stories about the Pharmaceutical industry
Last seen 10 hours ago • 6 views
Tile
https://www.pharmiweb.com/rss/articles RSS

PharmiWeb.com Articles

PharmiWeb.com | Articles in the Pharmaceutical industry
Last seen 10 hours ago • 5 views
Tile

View full article
Tile
Select a feed to view its content
Colossal Biosciences Hatches Live Chicks from Fully Artificial Eggs, Advancing the Path to Moa De-Extinction

Colossal Biosciences Hatches Live Chicks from Fully Artificial Eggs, Advancing the Path to Moa De-Extinction

Wed, 20 May 2026 12:39:00 +00:00
Glidewell Selects 43 Dentists for 2026 Guiding Leaders Cohort

Glidewell Selects 43 Dentists for 2026 Guiding Leaders Cohort

Wed, 20 May 2026 12:00:00 +00:00
Coulter Partners places Dr. Ferenc Tracik as Chief Medical Officer of Neumirna Therapeutics

Coulter Partners places Dr. Ferenc Tracik as Chief Medical Officer of Neumirna Therapeutics

Wed, 20 May 2026 11:09:02 +00:00
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows

QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows

Wed, 20 May 2026 11:05:00 +00:00
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00

Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00

Wed, 20 May 2026 10:15:00 +00:00
MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg®) in the treatment of acute Graft-versus-Host Disease

MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg®) in the treatment of acute Graft-versus-Host Disease

Wed, 20 May 2026 09:45:00 +00:00
Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy

Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy

Wed, 20 May 2026 09:33:00 +00:00
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

Wed, 20 May 2026 09:02:00 +00:00
Vyriad Launches G-Link: A Modular Platform Advancing T-Cell Targeted Lentiviral Vector Delivery for In Vivo and Ex Vivo Applications

Vyriad Launches G-Link: A Modular Platform Advancing T-Cell Targeted Lentiviral Vector Delivery for In Vivo and Ex Vivo Applications

Wed, 20 May 2026 09:00:00 +00:00
Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference

Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference

Wed, 20 May 2026 09:00:00 +00:00
Prolocor Announces Results of NIH-funded Study Demonstrating That Platelet FcγRIIa Identifies Cancer Patients at Increased Risk of Death and Thrombotic Events

Prolocor Announces Results of NIH-funded Study Demonstrating That Platelet FcγRIIa Identifies Cancer Patients at Increased Risk of Death and Thrombotic Events

Wed, 20 May 2026 09:00:00 +00:00
Factbird Adds Quality & Compliance and Reports to its Manufacturing Intelligence Platform

Factbird Adds Quality & Compliance and Reports to its Manufacturing Intelligence Platform

Wed, 20 May 2026 09:00:00 +00:00
Poxel Reports First Quarter 2026 Revenue and Provides a Business Update

Poxel Reports First Quarter 2026 Revenue and Provides a Business Update

Wed, 20 May 2026 09:00:00 +00:00
Chiesi Group Announces New Chair and Vice Chair

Chiesi Group Announces New Chair and Vice Chair

Wed, 20 May 2026 08:58:05 +00:00
TRNR Reports Q1 2026 Results, Driven By 279% Revenue Growth; Confirms 2026 Pro Forma Revenue Guidance of More Than $30m

TRNR Reports Q1 2026 Results, Driven By 279% Revenue Growth; Confirms 2026 Pro Forma Revenue Guidance of More Than $30m

Wed, 20 May 2026 08:30:00 +00:00
eschbach Unveils Seqonis, the Next Evolution of Its Intelligent Operations Platform

eschbach Unveils Seqonis, the Next Evolution of Its Intelligent Operations Platform

Wed, 20 May 2026 08:01:45 +00:00
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease

Wed, 20 May 2026 08:00:00 +00:00
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

Wed, 20 May 2026 07:45:00 +00:00
Greater Manchester launches Circulation Health: a new partnership to find and support people with chronic conditions earlier

Greater Manchester launches Circulation Health: a new partnership to find and support people with chronic conditions earlier

Wed, 20 May 2026 07:44:07 +00:00
InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities

InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities

Wed, 20 May 2026 07:26:00 +00:00